ArticleFrontiers in cardiovascular medicine2026
Percutaneous left renal vein stenting in posterior nutcracker syndrome: technical and antithrombotic nuances - a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Posterior Nutcracker Syndrome (PNCS) is a rare variant of left renal vein (LRV) entrapment in which the compression occurs between the abdominal aorta and vertebral column. Endovascular stenting may be considered in selected patients, but technical durability and antithrombotic management remain challenging. Case summary: A 64-year-old woman with chronic kidney disease and Child-Pugh A cirrhosis with portal hypertensive lesions was referred for percutaneous treatment of symptomatic PNCS. She had recurrent haematuria, left flank pain and recurrent lower urinary tract infections. Computed tomography (CT) demonstrated retroaortic LRV compression with a pre-stenotic-to-compressed segment diameter ratio of approximately 5:1 and collateral venous drainage. Dynamic renal scintigraphy showed reduced left renal uptake and invasive assessment demonstrated a 4 mmHg trans-stenotic gradient. A dedicated venous stent was deployed at the ostial LRV stenosis with limited protrusion into the inferior vena cava, achieving good expansion and no recoil. Post-procedural evolution was notable for left femoral venous access-site bleeding controlled with compression, while the LRV stent remained patent. In view of the newly implanted renal venous stent, cirrhosis-related haemostatic fragility, and early access-site bleeding, an individualized antithrombotic regimen was selected to balance stent thrombosis prevention against haemorrhagic risk, while acknowledging the current lack of standardized protocols for renal vein stenting. Discussion & conclusion: This case illustrates the importance of tailoring percutaneous treatment of PNCS to both anatomy and bleeding risk. In this patient, retroaortic ostial anatomy guided the stent deployment strategy, while early access-site bleeding in the setting of cirrhosis prompted individualized antithrombotic management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.